Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Contributeurs/tricesElzi, Luigia; Kaufmann, Gilbert; Weber, Rainer; Fux, C. A.; Cavassini, Matthias; Hirschel, Bernard; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel
Publié dansHIV clinical trials, vol. 10, no. 4, p. 207-214
Date de publication2009
Résumé
Mots-clés
- Adult
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes/immunology
- Cohort Studies
- Female
- HIV/genetics/ growth & development
- HIV Envelope Protein gp41/ administration & dosage
- HIV Fusion Inhibitors/ administration & dosage
- HIV Infections/blood/ drug therapy/immunology/virology
- Humans
- Kaplan-Meiers Estimate
- Male
- Middle Aged
- Peptide Fragments/ administration & dosage
- RNA, Viral/blood
Structure d'affiliation
Citation (format ISO)
ELZI, Luigia et al. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. In: HIV clinical trials, 2009, vol. 10, n° 4, p. 207–214. doi: 10.1310/hct1004-207
Identifiants
- PID : unige:9315
- DOI : 10.1310/hct1004-207
- PMID : 19723609
ISSN du journal1528-4336